DTx 101 Series 

Our four-part DTx 101 Series covers various aspects of the Digital Therapeutics (DTx) market to gain a better understanding into defining DTx and market trends, DTx business models, reimbursement considerations, and US FDA regulatory approaches.

Part 2 of our DTx 101 Series addresses the positioning of DTx business models.

Fill out the form to download Part 2 - Business Models: Getting Digital Therapeutics Into the Hands of Patients